Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment
RecruitingNCT07149038Phase: NAStarted 2025-10-15
Summary
This clinical trial evaluates the preliminary effectiveness and safety of Cerogrin, a medical device developed by Neurogrin Inc. for auricular vagus nerve stimulation, in patients with vascular dement
Eligibility
Sex
ALL
Min Age
55 Years
Max Age
89 Years
Locations
Dongtan Hallym University Sacred Heart HospitalHwaseong-si, Gyeonggi-do, South Korea
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07149038